1. |
Gulyás M, Kaposi AD, Elek G, et al.Value of carcinoenmbryonic antigen (CEA) and cholesterol assays of ascetic fluid in cases of inconclusive cytology.J Clin Pathol, 2001, 54(11):831-835.
|
2. |
Rana SV, Babu SG, Kocchar R.Usefulness of ascetic fluid cholesterol as a marker for malignant ascites.Med Sci Monit, 2005, 11(3):136-142.
|
3. |
罗春丽.临床检验基础.第3版.北京:人民卫生出版社, 2004:203-204.
|
4. |
Almakdisi T, Massoud S, Makdisi G.Lymphomas and chylous ascites:review of the literature.Oncologist, 2005, 10(8):632-635.
|
5. |
Balint PV, Kane D, Sturrock RD.Case number 26:massive cholesterol crystal deposition:unusual location in rheumatoid arthritis.Arm Rheum Dis, 2003, 62(6):512.
|
6. |
Bothenherg ME.Eosinophilic gastrointeatinal disorders (EGID).J Allergy Clin Immunol, 2004, 113(1):11-28.
|
7. |
Castaldo G, Oriani G, Cimino L, et al.Total discrimination of peritoneal malignant ascites from cirrhosis and hepato-carcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.Clin Chem, 1994, 40(3):478-483.
|
8. |
Kahn FY.Ascites in the state of Qatar:aetiology and diagnostic value of ascitic fluid analysis.Singapore Med J, 2007, 48(5):434-439.
|
9. |
王继见.门脉高压症发病机理的研究近况.中国普外基础与临床杂志, 2000, 7(4):275-276.
|
10. |
何远春, 李俊, 陈振东.胸腹水胆固醇测定对良恶性病变鉴别诊断的价值.安徽医科大学学报, 2009, 44(5):655-656.
|
11. |
Gerbes AL, Jungst D.Role of cholesterol determination in ascitic fluid analysis.Hepatology, 2009, 50(4):1320.
|
12. |
陈国平, 桂满元.胸腹水生化指标联合应用的临床诊断价值探讨.中外医学研究, 2011, 9(9):35-36.
|
13. |
刘辉, 左芳, 胡芳.胆固醇比值对胸腹水鉴别诊断的意义.检验医学与临床, 2007, 4(6):499.
|
14. |
张淑艳, 王海英, 熊慧顺.胸腹水与血清胆固醇联合测定对胸腹水性质的鉴别诊断意义.临床军医杂志, 2011, 39(5):907-908.
|
15. |
蔡根度, 吕雁群, 洪迎华, 等.胆固醇分析对良恶性腹水的诊断价值.上海医药检验杂志, 1996, 11(2):127.
|
16. |
盛裕芬.胸腹水/血清胆固醇比值鉴别胸腹水性质.临床检验杂志, 1994, 12(3):138.
|